Trial Profile
An Efficacy and Safety Study of PH-10 Aqueous Hydrogel for the Treatment of Plaque Psoriasis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Nov 2014
Price :
$35
*
At a glance
- Drugs Rose bengal sodium (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Provectus Biopharmaceuticals
- 06 Jul 2010 Actual end date (1 Apr 2010) added as reported by ClinicalTrials.gov.
- 06 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2009 Planned end date changed from 1 Apr 2010 to 1 Feb 2010 as reported by ClinicalTrials.gov.